J 2022

Deep brain stimulation of the anterior nuclei of the thalamus in focal epilepsy

DEUTSCHOVÁ, Barbora a Ivan REKTOR

Základní údaje

Originální název

Deep brain stimulation of the anterior nuclei of the thalamus in focal epilepsy

Autoři

DEUTSCHOVÁ, Barbora (203 Česká republika, domácí) a Ivan REKTOR (203 Česká republika, garant, domácí)

Vydání

Clinical Neurophysiology, Clare, Elsevier Ireland, 2022, 1388-2457

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30210 Clinical neurology

Stát vydavatele

Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 4.700

Kód RIV

RIV/00216224:14110/22:00129377

Organizační jednotka

Lékařská fakulta

UT WoS

000886064800001

Klíčová slova anglicky

Anterior thalamic nuclei; Focal epilepsy; Deep brain stimulation

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 18. 1. 2023 12:36, Mgr. Tereza Miškechová

Anotace

V originále

Objective: To review the therapeutic effects of deep brain stimulation of the anterior nuclei of the thala-mus (ANT-DBS) and the predictors of its effectiveness, safety, and adverse effects. Methods: A comprehensive search of the medical literature (PubMed) was conducted to identify relevant articles investigating ANT-DBS therapy for epilepsy. Out of 332 references, 77 focused on focal epilepsies were reviewed. Results: The DBS effect is probably due to decreased synchronization of epileptic activity in the cortex. The potential mechanisms from cellular to brain network levels are presented. The ANT might participate actively in the network elaborating focal seizures. The effects of ANT-DBS differed in various studies; ANT-DBS was linked with a 41% seizure frequency reduction at 1 year, 69% at 5 years, and 75% at 7 years. The most frequently reported adverse effects, depression and memory impairment, were considered non -serious in the long-term follow-up view. ANT-DBS also has been used in a few cases to treat status epilep-ticus. Conclusions: We reviewed the clinical literature and identified several factors that may predict seizure outcome following DBS therapy. More large-scale trials are required since there is a need to explore stim-ulation settings, apply patient-tailored therapy, and identify the presurgical predictors of patient response. Significance: A critical review of the published literature on ANT-DBS in focal epilepsy is presented. ANT-DBS mechanisms are not fully understood; possible explanations are provided. Biomarkers of ANT-DBS effectiveness may lead to patient-tailored therapy.

Návaznosti

GA21-25953S, projekt VaV
Název: Subkortikální jádra a kortikální funkce z perspektivy hluboké mozkové stimulace (Akronym: DBS3D)
Investor: Grantová agentura ČR, Subkortikální jádra a kortikální funkce z perspektivy hluboké mozkové stimulace